Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ETNB 89bio > Detailed Quotes

ETNB 89bio

Watchlist
13.240
+0.540+4.25%
Close  02/03 16:00 ET
13.280
+0.040+0.30%
Post Mkt Price 02/03 18:44 ET
High
13.260
Open
12.700
Turnover
13.28M
Low
12.390
Pre Close
12.700
Volume
1.02M
Market Cap
616.15M
P/E(TTM)
Loss
52wk High
13.260
Shares
46.54M
P/E(Static)
Loss
52wk Low
2.000
Float Cap
334.24M
Bid/Ask %
0.00%
Historical High
47.253
Shs Float
25.24M
Volume Ratio
1.13
Historical Low
2.000
Dividend TTM
--
Div Yield TTM
--
P/B
4.04
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
4.03%
Amplitude
6.85%
Avg Price
13.052
Lot Size
1
Float Cap
334.24M
Bid/Ask %
0.00%
Historical High
47.253
Shs Float
25.24M
Volume Ratio
1.13
Historical Low
2.000
Dividend TTM
--
P/B
4.04
Dividend LFY
--
Turnover Ratio
4.03%
Amplitude
6.85%
Avg Price
13.052
Lot Size
1
Price Forecast

News

Comment

Company Overview More
89bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded in January 2018 and is headquartered in San Francisco, CA.
CEO: Mr. Rohan Palekar
Market: NASDAQ
Listing Date: 11/11/2019
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist